These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 33915212)

  • 1. Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacy.
    Gupta Y; Maciorowski D; Zak SE; Kulkarni CV; Herbert AS; Durvasula R; Fareed J; Dye JM; Kempaiah P
    Int J Biol Macromol; 2021 Jul; 183():203-212. PubMed ID: 33915212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational repurposing approach for targeting the critical spike mutations in B.1.617.2 (delta), AY.1 (delta plus) and C.37 (lambda) SARS-CoV-2 variants using exhaustive structure-based virtual screening, molecular dynamic simulations and MM-PBSA methods.
    Ebrahimi M; Karami L; Alijanianzadeh M
    Comput Biol Med; 2022 Aug; 147():105709. PubMed ID: 35728285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries.
    David AB; Diamant E; Dor E; Barnea A; Natan N; Levin L; Chapman S; Mimran LC; Epstein E; Zichel R; Torgeman A
    Molecules; 2021 May; 26(11):. PubMed ID: 34072087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different compounds against Angiotensin-Converting Enzyme 2 (ACE2) receptor potentially containing the infectivity of SARS-CoV-2: an in silico study.
    Shahbazi B; Mafakher L; Teimoori-Toolabi L
    J Mol Model; 2022 Mar; 28(4):82. PubMed ID: 35249180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives.
    Tandon R; Sharp JS; Zhang F; Pomin VH; Ashpole NM; Mitra D; McCandless MG; Jin W; Liu H; Sharma P; Linhardt RJ
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33173010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms.
    Paiardi G; Richter S; Oreste P; Urbinati C; Rusnati M; Wade RC
    J Biol Chem; 2022 Feb; 298(2):101507. PubMed ID: 34929169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marine sulfated glycans inhibit the interaction of heparin with S-protein of SARS-CoV-2 Omicron XBB variant.
    He P; Song Y; Jin W; Li Y; Xia K; Kim SB; Dwivedi R; Farrag M; Bates J; Pomin VH; Wang C; Linhardt RJ; Dordick JS; Zhang F
    Glycoconj J; 2024 Apr; 41(2):163-174. PubMed ID: 38642280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions.
    Kim SY; Jin W; Sood A; Montgomery DW; Grant OC; Fuster MM; Fu L; Dordick JS; Woods RJ; Zhang F; Linhardt RJ
    Antiviral Res; 2020 Sep; 181():104873. PubMed ID: 32653452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve
    Shiliaev N; Lukash T; Palchevska O; Crossman DK; Green TJ; Crowley MR; Frolova EI; Frolov I
    J Virol; 2021 Oct; 95(21):e0135721. PubMed ID: 34406867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin.
    Mycroft-West CJ; Su D; Pagani I; Rudd TR; Elli S; Gandhi NS; Guimond SE; Miller GJ; Meneghetti MCZ; Nader HB; Li Y; Nunes QM; Procter P; Mancini N; Clementi M; Bisio A; Forsyth NR; Ferro V; Turnbull JE; Guerrini M; Fernig DG; Vicenzi E; Yates EA; Lima MA; Skidmore MA
    Thromb Haemost; 2020 Dec; 120(12):1700-1715. PubMed ID: 33368089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Feasible Alternative Strategy Targeting Furin Disrupts SARS-CoV-2 Infection Cycle.
    Mondal T; Shivange G; Habieb A; Tushir-Singh J
    Microbiol Spectr; 2022 Feb; 10(1):e0236421. PubMed ID: 35138160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular dynamic simulation analysis of SARS-CoV-2 spike mutations and evaluation of ACE2 from pets and wild animals for infection risk.
    Chen P; Wang J; Xu X; Li Y; Zhu Y; Li X; Li M; Hao P
    Comput Biol Chem; 2022 Feb; 96():107613. PubMed ID: 34896769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure based Drug Designing Approaches in SARS-CoV-2 Spike Inhibitor Design.
    Shanmugam A; Venkattappan A; Gromiha MM
    Curr Top Med Chem; 2022; 22(29):2396-2409. PubMed ID: 36330617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies.
    Mercurio I; Tragni V; Busto F; De Grassi A; Pierri CL
    Cell Mol Life Sci; 2021 Feb; 78(4):1501-1522. PubMed ID: 32623480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-SARS-CoV-2 Activity of Rhamnan Sulfate from
    Song Y; He P; Rodrigues AL; Datta P; Tandon R; Bates JT; Bierdeman MA; Chen C; Dordick J; Zhang F; Linhardt RJ
    Mar Drugs; 2021 Nov; 19(12):. PubMed ID: 34940684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics.
    Yesudhas D; Srivastava A; Gromiha MM
    Infection; 2021 Apr; 49(2):199-213. PubMed ID: 32886331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE2-Independent Interaction of SARS-CoV-2 Spike Protein with Human Epithelial Cells Is Inhibited by Unfractionated Heparin.
    Partridge LJ; Urwin L; Nicklin MJH; James DC; Green LR; Monk PN
    Cells; 2021 Jun; 10(6):. PubMed ID: 34200372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repositioning of histamine H
    Ge S; Wang X; Hou Y; Lv Y; Wang C; He H
    Eur J Pharmacol; 2021 Apr; 896():173897. PubMed ID: 33497607
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Sachdeva C; Wadhwa A; Kumari A; Hussain F; Jha P; Kaushik NK
    OMICS; 2020 Oct; 24(10):568-580. PubMed ID: 32757981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.
    Choudhury A; Mukherjee S
    J Med Virol; 2020 Oct; 92(10):2105-2113. PubMed ID: 32383269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.